Evidence map›Paper›PMID 32065331›Full record

SynthesisInternational urology and nephrology2020

Meta-analysis and systematic review of intermediate-term follow-up of prostatic urethral lift for benign prostatic hyperplasia.

Karthik Tanneru, Shiva Gautam, Daniel Norez, Jatinder Kumar, Muhammad Umar Alam, Shahriar Koocheckpour, K C Balaji, Costa Joseph

Abstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in International urology and nephrology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Karthik TanneruDepartment of Urology, University of Florida, 655 8th St W, Jacksonville, FL, 32209, USA.
Shiva GautamDepartment of Biostatistics, University of Florida, Jacksonville, FL, USA.
Daniel NorezDepartment of Biostatistics, University of Florida, Jacksonville, FL, USA.
Jatinder KumarDepartment of Urology, University of Florida, 655 8th St W, Jacksonville, FL, 32209, USA.
Muhammad Umar AlamDepartment of Urology, University of Florida, 655 8th St W, Jacksonville, FL, 32209, USA.
Shahriar KoocheckpourDepartment of Urology, University of Florida, 655 8th St W, Jacksonville, FL, 32209, USA.
K C BalajiDepartment of Urology, University of Florida, 655 8th St W, Jacksonville, FL, 32209, USA.
Costa JosephDepartment of Urology, University of Florida, 655 8th St W, Jacksonville, FL, 32209, USA. joseph.costa@jax.ufl.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundProstatic urethral lift (PUL), is a relatively new minimally invasive procedure for treatment of benign prostatic hyperplasia (BPH).This article is a systematic review and meta-analysis of all the articles published including follow-up of at least 24 months to analyze sustainability of results.

methodsWe performed a critical review in according to the preferred reporting items for systematic review and meta-analysis (PRISMA) guidelines. From a total 768 published articles that matched our search terms, 5 studies with minimum follow-up of 24 months were selected for comparison and data analyzed in terms of baseline characteristics, functional, and sexual health outcomes.

resultsIncluded in the analyses are five studies with a minimum follow-up of 24 months. A total of 386 patients underwent PUL and 322 patients (83.4%) are available for follow-up at 24 months. The randomized studies are grouped as group A and non-randomized studies as group B. At 24 months, the mean reduction in International Prostate Symptom Score (IPSS) from baseline was 9.1 in group A and 10.4 in group B. The mean improvement in peak flow rate (Q

conclusionPUL is a well-tolerated, minimally invasive therapy for BPH that provides favorable and durable symptomatic, sexual health, and functional outcomes up to 24 months. Longer follow-up and randomized studies comparing to current standards are required to further confirm the long-term sustainability of PUL.

Indexed as

Follow-Up StudiesHumansMaleProstatic HyperplasiaTime FactorsUrethraUrologic Surgical Procedures, MaleBPHLUTSProstatic urethral liftPULUrolift

Identifiers

PMID32065331

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.